简介：Pegylated interferon alfa in combination with ribavirin administered for 48 and 24 weeks has been approved as standard antiviral treatment in patients with HCV genotype 1 (4-6) and 2/3 infection， respectively， in many countries. Different virusand host-related baseline parameters are known to predict the probability of sustained virologic response including HCV genotype，